Abstract
The ability of marijuana to alter the course of viral infections was initially reported by Juel-Jensen in 1972.1. In this report, the author associated marijuana smoking with more frequent recurrences of herpes simplex virus (HSV) infections. This anecdotal report was made concerning only a few patients but was the impetus for examining the relationships among cannabinoids, immunity and progression of viral infections. The ability of cannabinoids, especially delta-9-tetrahydrocannabinol (THC), to alter immune functions is well described and has been reviewed.2 A summary of these findings is listed in Table 1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Juel-Jensen, B.E. Cannabis and recurrent herpes simplex. Brit. Med. J. 4: 296, 1972.
Friedman, H., Klein, T. and Specter, S. Immunosuppression by marijuana and components. In: Psychoneuroimmunology, 2nd Edition, Ader, R., Cohen, N. and Felten, D. (Eds), Academic Press, Orlando, 1991 pp. 931–953.
Morahan, P.S., Klykken, P.C., Smith, S.H., Harris, L.S. and Munson, A.E. Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23: 670–674, 1979.
Cabral, G.A., Mishkin, E.M. and Holsapple, M.P. Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the guinea pig. In: Marijuana 84. Proc. Oxford Symp. on Cannabis, IRL Press, 1985, pp. 431–438.
Cabral, G.A., Lockmuller, J.C. and Mishkin, E.M. Delta-9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F 1 mouse. Proc. Soc. Exp. Biol. Med. 181: 305–311, 1986.
Cabral, G.A., and Vasquez, R. Delta-9-tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity. Proc. Soc. Exp. Biol. Med. 199: 255–263, 1992.
Cabral, G.A., Dove-Pettit, D.A. and Fischer-Stenger, K. Marijuana and host resistance to herpesvirus infection. In: Drugs of Abuse, Immunity and AIDS Friedman, H., Klein, T.W. and Specter, S. (Eds.) Adv. Exp. Med. Biol. 335: 95–106, 1993.
Lancz, G., Specter, S. and Brown, H.K. Suppressive effects of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro. Proc. Soc. Exp. Biol. Med. 196: 401–404, 1991.
Lancz, G., Specter, S., Brown, H.K., Hackney, J.F. and Friedman, H. Interaction of delta-9-tetrahydrocannabinol with herpes simplex virus and cultural conditions associated with drug-induced anti-cellular effects. In: Drugs of Abuse, Immunity and Immunodeficiency, Friedman, H., Specter, S. and Klein, T (Eds.), Adv. Exp. Med. Biol. 288: 287–304, 1991.
Specter, S., Lancz, G., Westrich, G. and Friedman, H. Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus. In: Drugs of Abuse, Immunity and Immunodeficiency, Friedman, H., Specter, S. and Klein, T (Eds.), Adv. Exp. Med. Biol. 288: 135–142, 1991.
Specter, S., Lancz, G., Westrich, G. and Friedman, H. Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and opportunistic infection. Int. J. Immunopharmac. 13: 411–417, 1991.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Specter, S. (1996). Cannabinoids and Immunity to Viruses. In: Friedman, H., Eisenstein, T.K., Madden, J., Sharp, B.M. (eds) AIDS, Drugs of Abuse, and the Neuroimmune Axis. Advances in Experimental Medicine and Biology, vol 402. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0407-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0407-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8038-2
Online ISBN: 978-1-4613-0407-4
eBook Packages: Springer Book Archive